Hi reddit, my name is Daniel Irimia and I am an Associate Professor in the Surgery Department at Massachusetts General Hospital and Harvard Medical School, and a Senior Investigator at Shriners Burns Hospital in Boston. My research focuses on designing novel technologies for measuring the activities of white blood cells from patients, towards better ways to predict, diagnose, monitor, and treat inflammation, infections, and sepsis. In 2016, I received the “Pioneers of Miniaturization” prize from the Chemical and Biological Microsystems Society, for pioneering work on microfluidic technologies for measuring human neutrophil activities and applications to human diseases. I am the organizer of the recent Dicty World Race, an unorthodox approach aimed at encouraging biologists to employ emerging microfluidic technologies to make high precision measurements of cell migration for biological and medical research applications. The results and learning from this experiment were recently published as an article titled “A Worldwide Competition to Compare the Speed and Chemotactic Accuracy of Neutrophil-Like Cells” in PLOS ONE. The race enabled a large-scale comparison of motility and chemotaxis in the engineered cell lines, allowing exploration of a diverse set of strategies for enhancing chemotactic performance. We found that there are tradeoffs between cell speed and chemotactic accuracy in maze-like environments and that the winning cells were not the fastest cell type, but excelled in finding the shortest paths through the maze. These findings could eventually help us develop better therapies against infections and chronic inflammation. Don’t forget to follow me on Twitter @D__Irimia. I will be answering your questions at 1pm ET – Ask Me Anything!

Dr_Dean_Elterman

and 1 more

Hi Reddit! I’m Dr. Dean Elterman, a urologic surgeon at the University Health Network in Toronto. My focus on urology and its related diseases has led me to look more closely at how this field fits with overall male health. I’ve published research showing how the urologic community has a leading role to play in helping define the health issues that face men in the 21st century and improving their health outcomes and mortality rates. There are many factors such as ‘masculine identity’, social determinants and even the Y-chromosome itself that affect men’s health and longevity, and we’ve seen the evidence that up to 80 per cent of men refuse to see a physician until they are convinced by a spouse or partner to do so. The science and medical communities need to find ways to overcome these barriers so men can achieve good health, and one of those ways is through awareness and open discussion which is why I’m excited to host today’s AMA on what you need to know about your prostate health. Information about prostate health has changed a lot over the years. I’m happy to answer your questions about enlarged prostate, prostate cancer, the traditional and new treatments that exist for both, and when to consider having prostate health conversations with your healthcare practitioner. Note that I’m not able to provide medical advice online, but can point you in the direction of valuable online resources. I am live now and answering your questions– Ask me anything! AMA! Thanks very much for your thoughtful questions and for this important discussion. I am now done my AMA session - apologies if I didn’t get to answer your question and thank you for participating! To learn more about my research at the Krembil Research Institute and University of Toronto, [please click here] (https://uofturology.ca/directory/faculty/elterman-dean/). You can read other research I’ve worked on about how men’s health fits with urologic health here.
Hi Reddit, My name is Anirban Banerjee and I am an Assistant Professor at the Department of Biosciences & Bioengineering, Indian Institute of Technology Bombay, INDIA. I am a microbiologist and my research primarily focuses on the identification of various methods adopted by pathogens to breach different barriers in our body, such as the blood-brain barrier or feto-maternal barrier etc. We hope to learn from the smart tactics employed by these tiny creatures and apply them to deliver drugs across these barriers which are hard to penetrate. We recently published an article titled “Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth” in PLOS Pathogens. It is a well established fact that colonization of vagina and cervix of pregnant women with Group B Streptococcus (GBS), an opportunistic pathogen, significantly increases the probability of preterm birth. However, in fairly large number of cases the bacteria has not been detected in the feto-maternal interface and/or amniotic fluid. This led us to wonder how GBS sitting in the vagina can orchestrate events at the feto-maternal barrier. We were of the opinion that since rupture of amniotic membrane which is a prerequisite for preterm birth involves a complex series of events; this can only be augmented by a host of bacterial factors and not just simply one. Our findings suggest GBS produces membrane bound vesicles (MVs) that are loaded with multiple toxic proteins and enzymes of the bacteria. These MVs are capable of traveling up through the reproductive tract and lead to a series of deleterious effects resulting in extensive damage of the feto-maternal barrier (amniotic membrane) and subsequently preterm birth. This work was primarily done by four doctoral students in my lab (Manalee Surve, Anajali Anil, Kshama Kamath and Smita Bhutda) in collaboration with Dr. Deepak Modi, from National Institute for Research in Reproductive Health (NIRRH), Mumbai, INDIA. I will be answering your questions at 1pm ET – Ask Me Anything!

Christine_Stawitz

and 1 more

NanoHAC

and 1 more